Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2018 Sep 19:10:275.
doi: 10.3389/fnagi.2018.00275. eCollection 2018.

Healthy Aging and Dementia: Two Roads Diverging in Midlife?

Katie Irwin  1 , Claire Sexton  2   3 , Tarun Daniel  1 , Brian Lawlor  4   5 , Lorina Naci  5   6
Affiliations
Review

Healthy Aging and Dementia: Two Roads Diverging in Midlife?

Katie Irwin et al. Front Aging Neurosci. .

Abstract

Dementia, particularly Alzheimer's disease (AD), is a growing pandemic that presents profound challenges to healthcare systems, families, and societies throughout the world. By 2050, the number of people living with dementia worldwide could almost triple, from 47 to 132 million, with associated costs rising to $3 trillion. To reduce the future incidence of dementia, there is an immediate need for interventions that target the disease process from its earliest stages. Research programs are increasingly starting to focus on midlife as a critical period for the beginning of AD-related pathology, yet the indicators of the incipient disease process in asymptomatic individuals remain poorly understood. We address this important knowledge gap by examining evidence for cognitive and structural brain changes that may differentiate, from midlife, healthy aging and pathological AD-related processes. This review crystallizes emerging trends for divergence between the two and highlights current limitations and opportunities for future research in this area.

Keywords: Alzheimer’s disease; aging; cognition and brain structure; dementia; early markers; midlife.

PubMed Disclaimer

References

    1. Abner E. L., Dennis B. C., Mathews M. J., Mendiondo M. S., Caban-Holt A., Kryscio R. J., et al. (2012). Practice effects in a longitudinal, multi-center Alzheimer’s disease prevention clinical trial. Trials 13:217. 10.1186/1745-6215-13-217 - DOI - PMC - PubMed
    1. Adluru N., Destiche D. J., Lu S. Y., Doran S. T., Birdsill A. C., Melah K. E., et al. (2014). White matter microstructure in late middle-age: effects of apolipoprotein E4 and parental family history of Alzheimers disease. Neuroimage 4 730–742. 10.1016/j.nicl.2014.04.008 - DOI - PMC - PubMed
    1. Albert M. S., Dekosky S. T., Dickson D., Dubois B., Feldman H. H., Fox N. C., et al. (2011). The diagnosis of mild cognitive impairment due to Alzheimer’s disease: recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimers disease. Alzheimers Dement. 7 270–279. 10.1016/j.jalz.2011.03.008 - DOI - PMC - PubMed
    1. Alexander G. E., Bergfield K. L., Chen K., Reiman E. M., Hanson K. D., Lin L., et al. (2012). Gray matter network associated with risk for Alzheimers disease in young to middle-aged adults. Neurobiol. Aging 33 2723–2732. 10.1016/j.neurobiolaging.2012.01.014 - DOI - PMC - PubMed
    1. Alzheimer’s Association (2017). 2017 Alzheimers disease facts and figures. Alzheimers Dement. 13 325–373. 10.1016/j.jalz.2017.02.001 - DOI